Antifibrotic Effects of CXCL9 and Its Receptor CXCR3 in Livers of Mice and Humans

BACKGROUND & AIMS: Fibrosis is the hallmark of chronic liver diseases, yet many aspects of its mechanism remain to be defined. Chemokines are ubiquitous chemotactic molecules that mediate many acute and chronic inflammatory conditions, and CXC chemokine genes colocalize with a locus previously s...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: WASMUTH, HERMANN E., LAMMERT, FRANK, ZALDIVAR, MIRKO MORENO, WEISKIRCHEN, RALF, HELLERBRAND, CLAUS, SCHOLTEN, DAVID, BERRES, MARIE-LUISE, ZIMMERMANN, HENNING, STREETZ, KONRAD L., TACKE, FRANK, HILLEBRANDT, SONJA, SCHMITZ, PETRA, KEPPELER, HILDEGARD, BERG, THOMAS, DAHL, EDGAR, GASSLER, NIKOLAUS, FRIEDMAN, SCOTT L., TRAUTWEIN, CHRISTIAN
Format: Artigo
Langue:Inglês
Publié: 2009
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2892869/
https://ncbi.nlm.nih.gov/pubmed/19344719
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1053/j.gastro.2009.03.053
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires